Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinic of Oncology, University Hospital Center Zagreb
Zagreb, Croatia
- University Hospital for Tumors Zagreb
Zagreb, Croatia
- Clinique Armoricaine de Radiologie
Saint-Brieuc, France
- Nn Blokhin Russian Cancer Research Centre Rams
Moscow, Russia
- Republican Oncology Dispensary
Ufa, Russia
- Hospital Clínico San Carlos
Madrid, Spain
- Usc University of Southern California Keck School of Medicine
Los Angeles, California, United States
- Um Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- the University of Chicago
Chicago, Illinois, United States
- Weiss Memorial Hospital
Chicago, Illinois, United States
- Evanston Northwestern Healthcare
Evanston, Illinois, United States
- Joliet Oncology Hematology Associates
Joliet, Illinois, United States
- Fort Wayne Medical Oncology/hematology Inc.
Fort Wayne, Indiana, United States
- Ap&s Clinic, Llc
Terre Haute, Indiana, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Oncology Care Associates Pllc
Saint Joseph, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Kansas City Va Medical Center
Kansas City, Missouri, United States
- Roger Maris Cancer Center
Fargo, North Dakota, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Tennessee Cancer Institute
Memphis, Tennessee, United States
- Ut Health Science Center at San Antonio
San Antonio, Texas, United States
- Oncology Alliance
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2004
- Primary completion
- 31 Dec 2016
- Completion
- 31 Dec 2016
- Last update posted
- 9 Apr 2018
- Registered enrollment
- 285
- Registry id
- NCT00117572
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.